Status:
COMPLETED
Habit Reversal Training for Children and Adolescents With Trichotillomania
Lead Sponsor:
University of South Florida
Conditions:
Trichotillomania
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
The purpose of the current study is: 1. To evaluate the effectiveness of a habit reversal training (HRT) approach for children ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania...
Detailed Description
The purpose of this research study is to further investigate how well Habit Reversal Training (HRT) works to reduce hair-pulling symptoms in children and adolescents with trichotillomania (TTM). All ...
Eligibility Criteria
Inclusion
- Outpatient children between the ages of 7-17 years.
- Meets DSM-IV criteria for a primary diagnosis of TTM
- English speaking
Exclusion
- Lifetime DSM-IV bipolar, schizophrenia, or schizoaffective disorder, or substance abuse in past 6 months.
- A diagnosis of an autism spectrum disorders, mental retardation, or conduct disorder
- 1\) Current clinically significant suicidal intent, or 2) individuals who have engaged in suicidal behaviors within 6 months
- Receiving concurrent psychotherapy or behavioral interventions. Families will have the option of discontinuing such services to enroll in the study. Those randomized to treatment as usual (TAU) will be able to continue or initiate psychosocial interventions whereas those randomized to HRT will not receive other interventions concurrent with HRT.
- Any change in established psychotropic medication (e.g., antidepressants, anxioloytics) within 4 weeks before study enrollment, any change in antipsychotics within 3 weeks prior to the screening assessment, any change in fluoxetine or atamoxetine within 6 weeks of study enrollment, and any change in alpha-2 agonists or stimulants within 1 week of study enrollment. Those randomized to TAU may make medication changes following randomization, including starting a medication; those randomized to HRT will remain stable on medications during the study.
- Unwillingness of parents to make the commitment to accompany their child for multiple study visits, unwillingness to take part in randomization, inability to attend weekly sessions as therapist availability allows, inability to attend assessment visits.
- Presence of a significant and/or unstable medical illness which might lead to hospitalization during the study.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01445444
Start Date
September 1 2011
End Date
March 1 2016
Last Update
March 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Center for Pediatric Neuropsychiatry
St. Petersburg, Florida, United States, 33701